Please login to the form below

Not currently logged in
Email:
Password:

Phase 3 failure

This page shows the latest Phase 3 failure news and features for those working in and with pharma, biotech and healthcare.

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3

A heart failure drug initially developed by Cytokinetics and taken into phase 3 development by Amgen and Servier has widely disappointed investors despite showing some statistically significant results. ... Heart failure has become an increasingly

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2013 Pharma deals during November 2013

    This antibiotic kills Pseudomonas aeruginosa by a novel mechanism of action and has completed its phase 1 development. Under the agreement, Roche will make a $38m upfront payment with milestones of ... since the report that the phase 3 study had ended

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...